Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis

JAMA

Volumn 285, Issue 7, 2001, Pages 914-924

  Gould, Michael K ^a,b,d   Maclean, Courtney C ^a,d   Kuschner, Ware G ^c,d   Rydzak, Chara E ^a,d   Owens, Douglas K ^b,d  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b Health Services Research and Development Service   (United States)

^c Medical Service   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SAMPLE;

EID: 0035925107     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.7.914     Document Type: Review

References (83)

1. Evaluation and management of solitary and multiple pulmonary nodules
2. Managing solitary pulmonary nodules: The choice of strategy is a "close call."
3. Solitary pulmonary nodules: CT assessment
4. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis, I: Theory
5. Positron emission tomography imaging of the thorax
6. 18F-fluorodeoxyglucose PET scans in lung cancer
7. Usefulness of positron emission tomography imaging in the management of lung cancer
8. On the origin of cancer cells
9. The current status of clinical PET imaging
10. Current role of positron emission tomography in thoracic oncology
11. Satellite PET and lung cancer: A prospective study in surgical patients
12. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: Dual-head coincidence gamma camera versus positron emission tomographic scanner
13. Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning
14. Formulating questions and locating primary studies for inclusion in systematic reviews
15. Selecting and appraising studies for a systematic review
16. Diagnosis of lumbar spinal stenosis in adults: A metaanalysis of the accuracy of CT, MR, and myelography
17. Combining in-dependent studies of a diagnostic test into a summary ROC curve: Data-analytic approaches and some additional considerations
18. Polymerase chain reaction for the diagnosis of HIV infection in adults: A meta-analysis with recommendations for clinical practice and study design
19. Procedure guideline for tumor imaging using fluorine-18-FDG
20. A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants
21. Quantitative synthesis in systematic reviews
22. Publication bias
23. Recent advances of positron emission tomography and CT scan for the diagnosis of early cancer
24. Cancer screening with whole-body FDG PET
25. A clinical evaluation of the quantitative accuracy of simultaneous emission/transmission scanning in whole-body positron emission tomography
26. Positron emission tomography of lung cancer using 18F-2-fluoro-2deoxy-D-glucose and L-[11C-methyl]-methionine
27. Evaluation of pulmonary lesions with positron emission tomography
28. Triplehead SPECT with 2-[fluorine-18]fluoro-2-deoxy-Dglucose (FDG): Initial evaluation in oncology and comparison with FDG PET
29. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose
30. Evaluation of primary pulmonary carcinoid tumors using FDG PET
31. F-18-FDG positron imaging in oncological patients: Gamma camera coincidence detection versus dedicated PET
32. PET in oncology: Will it replace the other modalities?
33. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose
34. Staging of mediastinal nonsmall cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation
35. Cost effectiveness analysis of FDG-PET in the differential diagnosis and staging of lung cancer in Japan
36. Pulmonary abnormalities and PET data analysis: A retro-spective study
37. Evaluation of lung cancer by 99mTc-tetrofosmin SPECT: Comparison with [18F]FDG-PET
38. Differential diagnosis of lung tumor with positron emission tomography: A prospective study
39. Solitary pulmonary nodules: Detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose
40. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: Potential role in evaluation and management
41. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities
42. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose
43. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions: A comparative risk-benefit analysis
44. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)
45. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography
46. Characterization of chest masses by FDG positron emission tomography
47. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging
48. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET
49. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images
50. Evaluation of pulmonary lesions with FDG-PET: Comparison of findings in patients with and without a history of prior malignancy
51. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer
52. Likelihood of malignancy in a solitary pulmonary nodule: Comparison of Bayesian analysis and results of FDG-PET scan
53. Lymph node staging in nonsmall cell lung cancer: Evaluation by [18F]FDG positron emission tomography (PET)
54. Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography
55. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions
56. Prospective investigation of positron emission tomography in lung nodules
57. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum
58. Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scans in diagnosis of pulmonary nodules
59. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules
60. Fluorodeoxyglucose and bronchopulmonary cancer: Initial French results with positron emission tomography
61. Improvement of non-smallcell lung cancer staging by means of positron emission tomography
62. Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease
63. Value of PET-18FDG in lung cancer
64. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer
65. Initial evaluation of pulmonary abnormalities: CT-guided fineneedle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography correlation
66. Tc-99m MIBI scintigraphy in patients with lung cancer: Comparison with CT and fluorine-18 FDG PET imaging
67. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer
68. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma
69. Selective use of PET scan in the preoperative staging of NSCLC
70. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: Comparison with FDG PET
71. Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: Comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system
72. 18FDG in the primary staging of lung tumors: Results with a gamma camera and a 511 keV collimator
73. The clinical usefulness of F-18 FDG coincidence PET without attenuation correction and without wholebody scanning mode in pulmonary lesions: Comparison with CT, MRI, and clinical findings
74. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras
75. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT
76. T1 lung cancer: Prevalence of mediastinal nodal metastases and diagnostic accuracy of CT
77. The impact of thoracic computed tomography in clinically staged T1, N0, M0 chest lesions
78. Estimating the probability of malignancy in solitary pulmonary nodules: A Bayesian approach
79. The probability of malignancy in solitary pulmonary nodules: Application to small radiologically indeterminate nodules